EUVIMEDEUVIMED entdecken
Open Access

Voriconazole and Dexamethasone Drug Interaction in a Premature Neonate

Caren J Liviskie, Christine R Lockowitz, Christopher C McPherson, Melissa M Riley, David A Hunstad

The Journal of Pediatric Pharmacology and Therapeutics · 2026-08 · 31 (4) · 553-556

DOI: 10.5863/jppt-25-00085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pediatric Pharmacology and Therapeutics, 2026-08. Verfasst von Caren J Liviskie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy (CJL, CRL, CCM), St. Louis Children's Hospital, St. Louis, MO. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neonatal invasive fungal infections (IFI) from Aspergillus species are increasing in frequency. While voriconazole remains the antifungal of choice for treatment in many patient populations, several pharmacokinetic challenges affect dosing of voriconazole in premature neonates. Further complicating voriconazole use are the unknown implications of drug interactions in the preterm population. We report a case of voriconazole use in a neonate for the treatment of cutaneous Aspergillosis with variable serum voriconazole concentrations, reflecting a suspected drug interaction with dexamethasone. Serum voriconazole concentrations were initially subtherapeutic despite multiple dose escalations, then unexpectedly increased to supratherapeutic range as a concomitant dexamethasone course was tapered. Re-initiation of voriconazole after discontinuation of dexamethasone resulted in supratherapeutic concentrations that were discordant from previous serum concentrations on the same voriconazole dose while receiving dexamethasone. This is the first report of a potential drug interaction between voriconazole and a corticosteroid in a preterm neonate, highlighting the importance of drug interactions in voriconazole dosing evaluation and monitoring in this population.

Schlagwörter

Stichwörter der Autor:innen

drug interactionneonateprematurityvoriconazole

Autor:innen und Institutionen

  • Department of Pharmacy (CJL, CRL, CCM), St. Louis Children's Hospital, St. Louis, MO.
  • Department of Pediatrics (CCM, MMR, DAH), WashU Medicine, St. Louis, MO.

Zitieren

APA

Liviskie, C. J., Lockowitz, C. R., McPherson, C. C., Riley, M. M., & Hunstad, D. A. (2026). Voriconazole and Dexamethasone Drug Interaction in a Premature Neonate. The Journal of Pediatric Pharmacology and Therapeutics, 31(4), 553-556. https://doi.org/10.5863/jppt-25-00085

Vancouver

Liviskie CJ, Lockowitz CR, McPherson CC, Riley MM, Hunstad DA. Voriconazole and Dexamethasone Drug Interaction in a Premature Neonate. The Journal of Pediatric Pharmacology and Therapeutics. 2026;31(4):553-556. doi:10.5863/jppt-25-00085

BibTeX
@article{Liviskie2026,
  author = {Liviskie, Caren J and Lockowitz, Christine R and McPherson, Christopher C and Riley, Melissa M and Hunstad, David A},
  title = {Voriconazole and Dexamethasone Drug Interaction in a Premature Neonate},
  journal = {The Journal of Pediatric Pharmacology and Therapeutics},
  year = {2026},
  volume = {31},
  number = {4},
  pages = {553--556},
  doi = {10.5863/jppt-25-00085}
}
Kostenlos starten →